July 21, 2026 Across Healthcare Matrix Partners with C-Path to Expand Rare Disease Data Platform Through Direct Integration TUCSON, Ariz., July 21, 2026 — Critical Path Institute (C-Path), a nonprofit that builds data and analytics tools to speed drug.
July 16, 2026 Crown Bioscience Joins C-Path’s New Approach Methodologies Developer Coalition TUCSON, Ariz., July 16, 2026 — Critical Path Institute's® (C-Path) New Approach Methodologies Developer Coalition...
July 14, 2026 Karen Bernstein, One of Biotech’s Most Influential Voices, Elected C-Path Board Chair TUCSON, Ariz., July 14, 2026 — Critical Path Institute® (C-Path) today announced that its Board of Directors has elected...
July 9, 2026 C-Path Awards $250,000 Grant to Advance New Treatment for Sepsis-Associated Neurocognitive Dysfunction TUCSON, Ariz., July 9, 2026 — Critical Path Institute® (C-Path) has awarded a $250,000 research grant to Teresa Sanchez, Ph.D.,
June 15, 2026 C-Path Reaffirms Commitment to Advancing Regulatory Science for Disease-Modifying Therapies in Type 1 Diabetes TUCSON, Ariz., June 15, 2026 — Critical Path Institute® (C-Path), through its Type 1 Diabetes Consortium, today...
June 11, 2026 C-Path Appoints Biotech Executive and Investor Dr. Milad Alucozai to Board of Directors TUCSON, Ariz., June 11, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Milad Alucozai...
June 10, 2026 C-Path Appoints Biotechnology Leader and Veteran Life-Science Attorney Yalonda Howze to Board of Directors TUCSON, Ariz., June 10, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Yalonda Howze...
June 9, 2026 Critical Path Institute to Convene Drug Development Leaders at 2026 Global Impact Conference TUCSON, Ariz., June 9, 2026 — Critical Path Institute® (C-Path) will host its 2026 Global Impact Conference (CGIC) this...
May 20, 2026 Critical Path Institute Awards $249,719 Grant to Odylia Therapeutics to Advance Gene Therapy for USH1C-Associated Vision Loss TUCSON, Ariz., May 20, 2026 — Critical Path Institute® (C-Path) today announced the award of a $249,719 research grant...
May 19, 2026 Critical Path Institute Launches New Approach Methodologies Developer Coalition to Advance Human-Relevant Tools for Drug Development TUCSON, Ariz., and AMSTERDAM, May 19, 2026 — Critical Path Institute® (C-Path) today announced the launch of the New...